• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Axcelis Announces Financial Results for Second Quarter 2023

    8/2/23 4:01:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology
    Get the next $ACLS alert in real time by email

    Financial Results Exceed Guidance Driven by Strong Purion Demand and Strength in Power Devices

    BEVERLY, Mass., Aug. 2, 2023 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter of 2023.

    Axcelis (PRNewsfoto/Axcelis Technologies, Inc.)

    Highlights include:

    • The Company reported second quarter revenue of $274.0 million, compared to $254.0 million for the first quarter of 2023.
    • Operating profit for the quarter was $63.7 million, compared to $51.4 million for the first quarter.
    • Net income for the quarter was $61.6 million, or $1.86 per diluted share, compared to $47.7 million, or $1.43 per diluted share in the first quarter.
    • Gross margin for the quarter was 43.7%, compared to 40.9% in the first quarter.
    • Second quarter ended with systems backlog of $1.23 billion on quarterly bookings of $193 million.
    Financial Results Exceed Guidance Driven by Strong Purion Demand and Strength in Power Devices

    President and CEO Russell Low commented, "Axcelis delivered strong second quarter financial performance as a result of significant demand for the Purion product family, especially in the silicon carbide power market. Axcelis is the only company with a product line capable of covering all implant recipes in the mature process technology markets. We now believe it is possible to achieve $1.3 billion in revenue in the next one or two years, depending on market conditions."

    Executive Vice President and Chief Financial Officer Kevin Brewer said, "We are very pleased with our second quarter 2023 financial results which finished well above guidance due to solid execution and continuing strong demand for Purion. We are upwardly revising expectations for 2023 revenue to greater than $1.1 billion, representing year over year growth of approximately 20%."

    Business Outlook

    For the third quarter ending September 30, 2023, Axcelis expects revenues of approximately $280 million. Gross margin in the third quarter is expected to be approximately 44%. Third quarter operating profit is forecast to be approximately $64 million with earnings per diluted share of approximately $1.72. For the full year, the Company expects to achieve revenue greater than $1.1 billion and to achieve full year gross margins of approximately 44% as shown in the $1.1 billion model.

    Second Quarter 2023 Conference Call

    The Company will host a call to discuss the results for the second quarter on Thursday, August 3, 2023, at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a Participant here: https://register.vevent.com/register/BI9757e7e7d17f4188872f4146e314ba26. Webcast replays will be available for 30 days following the call.

    Safe Harbor Statement

    This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for revenues, gross margin, operating profit and other guidance for our future financial performance and spending in our industry, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

    About Axcelis:

    Axcelis (NASDAQ:ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

    Company Contacts

    Investor Relations:

    Doug Lawson

    978.787.9552

    Editorial/Media:

    Maureen Hart

    978.787.4266

    Axcelis Technologies, Inc.

    Consolidated Statements of Operations

    (In thousands, except per share amounts)

    (Unaudited)

































    Three months ended 



    Six months ended









    June 30,



    June 30,







    2023



    2022



    2023



    2022



    Revenue:



























    Product



    $

    265,673



    $

    213,926



    $

    511,680



    $

    410,458



    Services





    8,297





    7,251





    16,310





    14,314



    Total revenue





    273,970





    221,177





    527,990





    424,772



    Cost of revenue:



























    Product





    146,741





    115,754





    289,512





    223,395



    Services





    7,526





    6,242





    14,756





    12,429



    Total cost of revenue





    154,267





    121,996





    304,268





    235,824



    Gross profit





    119,703





    99,181





    223,722





    188,948



    Operating expenses:



























    Research and development





    24,130





    18,731





    47,903





    35,704



    Sales and marketing





    15,537





    12,703





    29,681





    23,994



    General and administrative





    16,328





    13,602





    31,073





    26,180



    Total operating expenses





    55,995





    45,036





    108,657





    85,878



    Income from operations





    63,708





    54,145





    115,065





    103,070



    Other income (expense):



























    Interest income





    4,307





    352





    8,243





    447



    Interest expense





    (1,349)





    (1,250)





    (2,702)





    (2,768)



    Other, net





    (2,050)





    (5,051)





    (3,088)





    (6,669)



    Total other income (expense)





    908





    (5,949)





    2,453





    (8,990)



    Income before income taxes





    64,616





    48,196





    117,518





    94,080



    Income tax provision





    3,037





    4,007





    8,242





    8,276



    Net income



    $

    61,579



    $

    44,189



    $

    109,276



    $

    85,804



    Net income per share:



























    Basic



    $

    1.88



    $

    1.34



    $

    3.34



    $

    2.59



    Diluted



    $

    1.86



    $

    1.32



    $

    3.29



    $

    2.54



    Shares used in computing net income per share:



























    Basic weighted average shares of common stock





    32,775





    33,096





    32,759





    33,170



    Diluted weighted average shares of common stock





    33,189





    33,562





    33,237





    33,770



     

    Axcelis Technologies, Inc.

    Consolidated Balance Sheets

    (In thousands, except per share amounts)

    (Unaudited)





















    June 30,



    December 31,







    2023



    2022



    ASSETS



    Current assets:















    Cash and cash equivalents



    $

    132,504



    $

    185,595



    Short-term investments





    320,360





    246,571



    Accounts receivable, net





    159,199





    169,773



    Inventories, net





    299,841





    242,406



    Prepaid expenses and other current assets





    38,265





    33,300



    Total current assets





    950,169





    877,645



    Property, plant and equipment, net





    43,156





    39,664



    Operating lease assets





    31,998





    12,146



    Finance lease assets, net





    17,305





    17,942



    Long-term restricted cash





    6,652





    752



    Deferred income taxes





    38,944





    31,701



    Other assets





    33,494





    33,791



    Total assets



    $

    1,121,718



    $

    1,013,641



    LIABILITIES AND STOCKHOLDERS' EQUITY



    Current liabilities:















    Accounts payable



    $

    60,504



    $

    62,346



    Accrued compensation





    17,216





    35,540



    Warranty





    10,867





    8,299



    Income taxes





    6,598





    4,304



    Deferred revenue





    138,890





    123,471



    Current portion of finance lease obligation





    1,367





    1,229



    Other current liabilities





    13,018





    12,943



    Total current liabilities





    248,460





    248,132



    Long-term finance lease obligation





    44,455





    45,185



    Long-term deferred revenue





    43,650





    31,306



    Other long-term liabilities





    41,116





    21,762



    Total liabilities





    377,681





    346,385



















    Stockholders' equity:















    Common stock, $0.001 par value, 75,000 shares authorized; 32,836 shares issued and

    outstanding at June 30, 2023; 32,775 shares issued and outstanding at December 31, 2022





    33





    33



    Additional paid-in capital





    540,120





    550,299



    Retained earnings





    206,813





    118,892



    Accumulated other comprehensive loss





    (2,929)





    (1,968)



    Total stockholders' equity





    744,037





    667,256



    Total liabilities and stockholders' equity



    $

    1,121,718



    $

    1,013,641



















     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-financial-results-for-second-quarter-2023-301891866.html

    SOURCE Axcelis Technologies, Inc.

    Get the next $ACLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLS

    DatePrice TargetRatingAnalyst
    10/13/2025$90.00Neutral → Underperform
    BofA Securities
    10/2/2025$105.00Hold → Buy
    The Benchmark Company
    4/21/2025$50.00Buy → Neutral
    B. Riley Securities
    2/12/2025Outperform → Mkt Perform
    William Blair
    11/8/2024Buy → Hold
    The Benchmark Company
    5/3/2024$130.00Hold → Buy
    Craig Hallum
    12/15/2023Buy → Neutral
    BofA Securities
    9/15/2023$225.00Buy
    BofA Securities
    More analyst ratings

    $ACLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Axcelis Stockholders Approve Merger with Veeco

    BEVERLY, Mass., Feb. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) ("Axcelis") today announced that its stockholders have voted to approve all proposals related to the Company's pending merger (the "Merger") with Veeco Instruments Inc. (NASDAQ:VECO) at its Special Meeting of Stockholders ("Special Meeting"). The final voting results of the Special Meeting will be reported in a Form 8-K filed by Axcelis with the U.S. Securities and Exchange Commission. The completion of the Merger remains subject to other customary closing conditions, including the final pend

    2/6/26 4:10:00 PM ET
    $ACLS
    $VECO
    Industrial Machinery/Components
    Technology

    Veeco Stockholders Approve Merger with Axcelis

    PLAINVIEW, N.Y., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ:VECO) ("Veeco") today announced that its stockholders have voted to approve all proposals related to the Company's pending merger (the "Merger") with Axcelis Technologies, Inc. (NASDAQ:ACLS) ("Axcelis") at its Special Meeting of Stockholders ("Special Meeting"). The final voting results of the Special Meeting will be reported in a Form 8-K filed by Veeco with the U.S. Securities and Exchange Commission. The completion of the Merger remains subject to other customary closing conditions, including the final pending regulatory approval from the State Administration for Market Regulation of the People's Republi

    2/6/26 4:10:00 PM ET
    $ACLS
    $VECO
    Industrial Machinery/Components
    Technology

    Axcelis Announces Participation in SEMICON Korea 2026

    Highlighting New Technologies That Advance Intelligent Semiconductor Manufacturing Solutions BEVERLY, Mass., Feb. 4, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2026. The event will take place February 11–13 at the COEX Center in Seoul, South Korea. SEMICON Korea will feature key technology developments shaping the next generation of semiconductor manufacturing, including AI driven process control, advanced packaging methodologies, and sustainable, high efficiency fab operations.

    2/4/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    SEC Filings

    View All

    SEC Form 425 filed by Axcelis Technologies Inc.

    425 - AXCELIS TECHNOLOGIES INC (0001113232) (Filed by)

    2/12/26 5:22:09 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SCHEDULE 13G filed by Axcelis Technologies Inc.

    SCHEDULE 13G - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/12/26 4:05:49 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form 425 filed by Axcelis Technologies Inc.

    425 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/6/26 4:41:38 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ACLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ACLS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Axcelis Tech downgraded by BofA Securities with a new price target

    BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00

    10/13/25 8:47:48 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00

    10/2/25 8:33:47 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Tech downgraded by B. Riley Securities with a new price target

    B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00

    4/21/25 8:31:51 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    EVP Global Operations Mahoney Robert John was granted 1,734 shares, increasing direct ownership by 13% to 15,206 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    1/16/26 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    New insider Mahoney Robert John claimed ownership of 13,472 shares (SEC Form 3)

    3 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    12/22/25 5:09:43 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    EVP, General Counsel and Sec'y Evans Eileen covered exercise/tax liability with 1,378 shares, decreasing direct ownership by 5% to 24,406 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    12/18/25 5:05:05 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Low Russell bought $49,452 worth of shares (440 units at $112.39), increasing direct ownership by 0.77% to 57,754 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    3/11/24 4:15:28 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Coogan James Gordon bought $11,223 worth of shares (100 units at $112.23), increasing direct ownership by 2% to 5,991 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/29/24 4:15:26 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Lawson Douglas A. bought $55,520 worth of shares (500 units at $111.04), increasing direct ownership by 3% to 19,648 units (SEC Form 4)

    4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)

    2/26/24 8:15:07 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Leadership Updates

    Live Leadership Updates

    View All

    Axcelis Technologies Appoints David Ryzhik Senior Vice President of Investor Relations and Corporate Strategy

    The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.

    6/27/24 4:01:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Shipment of 'Purion EXE SiC Power Series' Implanter and Successful 'Purion H200 SiC Power Series' Eval Closure at Leading Power Device Manufacturers in Japan

    BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,

    4/2/24 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    ClearPoint Neuro, Inc. Announces Appointment of Lynnette C. Fallon to Board of Directors

    SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin

    7/15/21 4:30:00 PM ET
    $CLPT
    $ACLS
    Medical/Dental Instruments
    Health Care
    Industrial Machinery/Components
    Technology

    $ACLS
    Financials

    Live finance-specific insights

    View All

    Axcelis Announces Timing and Availability of Fourth Quarter and Full Year 2025 Results and Conference Call

    BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register

    1/26/26 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Financial Results for Third Quarter 2025

    Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased

    11/4/25 7:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    Axcelis Announces Timing and Availability of Third Quarter 2025 Results and Conference Call

    BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c

    10/22/25 8:00:00 AM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    $ACLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Axcelis Technologies Inc.

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    11/8/24 2:17:22 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/13/24 4:58:56 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Axcelis Technologies Inc. (Amendment)

    SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)

    2/9/24 4:18:00 PM ET
    $ACLS
    Industrial Machinery/Components
    Technology